To defend its core business, Amgen argued that the biosimilars they produced for the U.S. market were different from generic drugs. The company created more awareness of its business to protect its interests and products. In Europe, Amgen took the path of a reputable and valued innovator to defend itself. It sought to protect its business from competition from other parties in the healthcare domain. New entrants and producers of biosimilars and generic drugs were the targets of Amgen’s defense.
What arguments did Amgen use to defend its core business?
Cite this page
References
Academic.Tips. (2023) 'What arguments did Amgen use to defend its core business'. 12 March.
Reference
Academic.Tips. (2023, March 12). What arguments did Amgen use to defend its core business? https://academic.tips/question/what-arguments-did-amgen-use-to-defend-its-core-business/
References
Academic.Tips. 2023. "What arguments did Amgen use to defend its core business?" March 12, 2023. https://academic.tips/question/what-arguments-did-amgen-use-to-defend-its-core-business/.
1. Academic.Tips. "What arguments did Amgen use to defend its core business?" March 12, 2023. https://academic.tips/question/what-arguments-did-amgen-use-to-defend-its-core-business/.
Bibliography
Academic.Tips. "What arguments did Amgen use to defend its core business?" March 12, 2023. https://academic.tips/question/what-arguments-did-amgen-use-to-defend-its-core-business/.
Work Cited
"What arguments did Amgen use to defend its core business?" Academic.Tips, 12 Mar. 2023, academic.tips/question/what-arguments-did-amgen-use-to-defend-its-core-business/.